CNC
Centene CorpPrice & Indicators
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
TL;DR.
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders BuyIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from its earnings releases, calls, and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Commercial HBR | 75.3% | Q1 2026 | — |
|
|
|||
| Medicaid HBR | 93.1% | Q1 2026 | — |
| Medicare HBR | 84.9% | Q1 2026 | — |
| Total at-risk membership | 26,272,900 | March 31, 2026 | — |
| Total Commercial membership | 4,063,200 | March 31, 2026 | — |
| Total Medicaid membership | 12,426,900 | March 31, 2026 | — |
| decedent membership as percentage of overall Medicare portfolio | 40% | Q1 2026 call | — |
| Marketplace members | 3.6M | Q1 2026 call | — |
| PDP members | 8.7M | Q1 2026 call | — |
| Adjusted SG&A expense ratio non-GAAP | 7.4% | Full Year 2025 | — |
| Health benefits ratio | 94.3% | Q4 2025 | — |
Figures exactly as the company stated them · click a metric with a to chart its history · period links open the stating document · "call" marks figures stated on the earnings call, "filing" figures stated in the 10-K/10-Q · YoY needs the prior-year figure on file
Versus peers
Healthcare Plans — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
CNC
this stock
Centene Corp
|
$32.65B | +60.7% | +19.4% | — | 3.0% |
|
UNH
Unitedhealth Group Inc
|
$388.86B | +30.7% | +11.8% | 32.2 | 1.9% |
|
CVS
CVS HEALTH Corp
|
$133.30B | +32.7% | +10.9% | 45.8 | 1.8% |
|
ELV
Elevance Health, Inc.
|
$90.96B | +20.2% | +9.4% | 17.8 | 2.9% |
|
CI
Cigna Group
|
$75.82B | +4.7% | +11.2% | 12.2 | 2.8% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| CNC | +2.5% | +6.1% | +42.5% | +3.0% | +60.7% |
| SPY | +0.9% | +1.4% | +7.6% | +0.1% | +9.7% |
| vs SPY | +1.5% | +4.7% | +35.0% | +2.9% | +51.0% |
Capital returns
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.